This trial will test how safe and effective the Edwards EVOQUE tricuspid valve replacement system is.
3 Primary · 1 Secondary · Reporting Duration: 1 year
Active Control
Experimental Treatment
820 Total Participants · 3 Treatment Groups
Primary Treatment: Edwards EVOQUE System · No Placebo Group · N/A
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: